Sponsored Links
  • ODI Orthodynamics Company 1300x380
  • HESC Sponsors Ad 1300x380 Abiomed Biomed Simulation
  • VitalGo Systems 1300x380
  • HESC Sponsors Ad 1300x380 CLR Essential Pharma
  • Medtronic 1300x380
  • HESC Sponsors Ad 1300x380 Abbot Indiana Donor Network
  • Abbott 1300x380
  • EigenFlow 2 Advanced 1300x380
  • Grifols 1300x380

Anti‑Xa activity and Hemorrhagic Events Under Extracorporeal Membrane Oxygenation

Usage of Veno-Venous (V-V) and Veno-Arterial (V-A) Extra-Corporeal Membrane Oxygenation (ECMO) is increasingly common in ICU setups. This carries a risk of numerous complications, and among them, hemorrhagic events result in high mortality. These events occur due to anticoagulants used for preventing thromboembolic events and clotting inside the equipment used in ECMO. To monitor the…

Login in to view this article:

You need to be logged in to view the rest of this article. Don't have an account? Register for one below.

Subscribe
Notify of

0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Sponsored Links
  • Beating Heart Newsletter Ad
  • EigenFlow 2 Advanced 800x800
  • HBP Place Ad Here

Stay Informed! Sign up for our newsletter.

Stay informed with new article notifications and updates. Your email is used for article notification and update purposes only and will never be used for spam.

0
Would love your thoughts, please comment.x
()
x